EGFR and breast neoplasm: Patient BC1 was first diagnosed in early stage BC (T1N0M0), with somatic mutations in TP53, CDK12, EGFR, and PTCH1 (OMIM 601309) in the original breast tumor, and these mutations could also be detected in the liver metastasis samples with increased allele frequencies (Figure 3b).